House Panel Moves to Hold Pam Bondi in Contempt Over Epstein Files

The House committee investigating the Epstein scandal is escalating its fight for transparency by moving to hold former Florida Attorney General Pam Bondi in contempt. Bondi, who possesses critical information about the Trump administration's handling of Epstein-related documents, has refused to cooperate, skipping a key deposition.

Source ↗
Only Clowns Are Orange

The House committee probing the Epstein files has taken a sharp turn toward accountability, moving to hold former Florida Attorney General Pam Bondi in contempt of Congress. Bondi, a figure with intimate knowledge of the Trump administration's approach to Epstein-related documents, has repeatedly stonewalled the investigation by refusing to comply with subpoenas and skipping a scheduled deposition.

This contempt move signals the committee's frustration with Bondi's evasiveness. According to sources familiar with the matter, Bondi's testimony is crucial to understanding how the Trump administration managed, and potentially suppressed, sensitive information tied to Jeffrey Epstein's trafficking network and its powerful enablers.

Bondi's refusal to cooperate fits a troubling pattern of obstruction by individuals linked to Epstein and the Trump orbit. It raises urgent questions about what the administration might be hiding and why key players are so determined to block congressional scrutiny.

The Epstein files investigation is not just about one disgraced financier. It is about exposing the systemic failures and cover-ups that allowed exploitation to flourish unchecked. Bondi's contempt move underscores the stakes: without full transparency and accountability, justice for survivors remains out of reach.

As the committee presses forward, this confrontation with Bondi could be a pivotal moment in the fight to pierce the veil of secrecy surrounding Epstein's powerful enablers and the Trump administration's role in shielding them. We will be watching closely as this unfolds.

Filed under:

Comments (0)

No comments yet. Be the first to share your thoughts.

Sign in to leave a comment.